Free Trial
NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Price, News & Analysis

OrthoPediatrics logo
$18.53 +0.38 (+2.09%)
Closing price 04:00 PM Eastern
Extended Trading
$18.53 0.00 (0.00%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About OrthoPediatrics Stock (NASDAQ:KIDS)

Advanced

Key Stats

Today's Range
$18.00
$18.64
50-Day Range
$14.64
$18.50
52-Week Range
$14.42
$23.70
Volume
64,921 shs
Average Volume
157,267 shs
Market Capitalization
$475.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.44
Consensus Rating
Moderate Buy

Company Overview

OrthoPediatrics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

KIDS MarketRank™: 

OrthoPediatrics scored higher than 59% of companies evaluated by MarketBeat, and ranked 399th out of 855 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 9 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    OrthoPediatrics has a consensus price target of $24.44, representing about 32.0% upside from its current price of $18.51.

  • Amount of Analyst Coverage

    OrthoPediatrics has only been the subject of 3 research reports in the past 90 days.

  • Read more about OrthoPediatrics' stock forecast and price target.
  • Earnings Growth

    Earnings for OrthoPediatrics are expected to grow in the coming year, from ($1.13) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OrthoPediatrics is -11.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OrthoPediatrics is -11.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    OrthoPediatrics has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about OrthoPediatrics' valuation and earnings.
  • Percentage of Shares Shorted

    5.21% of the float of OrthoPediatrics has been sold short.
  • Short Interest Ratio / Days to Cover

    OrthoPediatrics has a short interest ratio ("days to cover") of 7.61.
  • Change versus previous month

    Short interest in OrthoPediatrics has recently decreased by 3.69%, indicating that investor sentiment is improving.
  • Dividend Yield

    OrthoPediatrics does not currently pay a dividend.

  • Dividend Growth

    OrthoPediatrics does not have a long track record of dividend growth.

  • News Sentiment

    OrthoPediatrics has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for OrthoPediatrics this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,003,450.00 in company stock.

  • Percentage Held by Insiders

    31.80% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OrthoPediatrics' insider trading history.
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KIDS Stock News Headlines

Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
See More Headlines

KIDS Stock Analysis - Frequently Asked Questions

OrthoPediatrics' stock was trading at $17.76 at the beginning of 2026. Since then, KIDS shares have increased by 4.2% and is now trading at $18.5120.

OrthoPediatrics Corp. (NASDAQ:KIDS) posted its quarterly earnings data on Thursday, April, 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.04. The business earned $59.36 million during the quarter, compared to analysts' expectations of $58.29 million. OrthoPediatrics had a negative net margin of 16.31% and a negative trailing twelve-month return on equity of 7.01%.
Read the conference call transcript
.

OrthoPediatrics (KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

Top institutional investors of OrthoPediatrics include Granahan Investment Management LLC (3.49%), Dimensional Fund Advisors LP (2.13%), Wasatch Advisors LP (1.30%) and Roubaix Capital LLC (1.13%). Insiders that own company stock include David R Bailey, Fred Hite, Joseph W Hauser, Gregory A Odle, Daniel J Gerritzen, Mark C Throdahl and Terry D Schlotterback.
View institutional ownership trends
.

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
4/30/2026
Today
6/16/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:KIDS
CIK
1425450
Employees
200
Year Founded
2006

Price Target and Rating

High Price Target
$34.00
Low Price Target
$17.00
Potential Upside/Downside
+31.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.65 million
Net Margins
-16.31%
Pretax Margin
-16.27%
Return on Equity
-7.01%
Return on Assets
-4.86%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
5.21
Quick Ratio
2.37

Sales & Book Value

Annual Sales
$236.35 million
Price / Sales
2.01
Cash Flow
$0.17 per share
Price / Cash Flow
107.17
Book Value
$13.82 per share
Price / Book
1.34

Miscellaneous

Outstanding Shares
25,680,000
Free Float
17,517,000
Market Cap
$475.85 million
Optionable
Optionable
Beta
1.03

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:KIDS) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners